Biomind Labs Inc.
BMND
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 80.20K | 551.90K | 87.00K | 92.50K | 113.00K |
| Depreciation & Amortization | -- | 0.00 | -- | -- | 2.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.20K | 551.90K | 87.00K | 92.50K | 115.20K |
| Operating Income | -80.20K | -551.90K | -87.00K | -92.50K | -115.20K |
| Income Before Tax | -104.10K | -564.30K | -102.80K | -116.50K | -66.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -104.10K | -564.30K | -102.80K | -116.50K | -66.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -104.10K | -564.30K | -102.80K | -116.50K | -66.80K |
| EBIT | -80.20K | -551.90K | -87.00K | -92.50K | -115.20K |
| EBITDA | -79.70K | -551.90K | -87.00K | -92.50K | -113.00K |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 77.57M | 77.57M | 77.57M | 77.57M | 77.57M |
| Average Diluted Shares Outstanding | 77.57M | 77.57M | 77.57M | 77.57M | 77.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |